clusters. [3][4][5][6] Recently, the degree of hepatic inflammatory ac-Hepatitis C virus (HCV) causes acute and often also chronic tivity has been shown to be positively correlated to the exliver disease. Hepatocellular injury might result from both a pression of interferon-gamma (IFN-g) transcripts
Metoprolol-induced hepatitis: Is the rate of oxidation related to drug-induced hepatotoxicity?
β Scribed by M. S. Lennard
- Publisher
- John Wiley and Sons
- Year
- 1989
- Tongue
- English
- Weight
- 257 KB
- Volume
- 9
- Category
- Article
- ISSN
- 0270-9139
No coin nor oath required. For personal study only.
β¦ Synopsis
Metoprolol is a widely used beta-adrenoreceptor antagonist. There is no report of hepatitis involving this drug as well as other beta-adrenoreceptor antagonists. Metoprolol is metabolized by three major oxidation pathways. Two of them, 0- dealkylation and alpha-hydroxylation, undergo genetically controlled polymorphisms correlated with that of debrisoquine oxidation. This finding strongly suggests that metoprolol oxidation depends at least partly on the same isozyme of cytochrome P-450 involved in the genetic polymorphism of oxidation of debrisoquine and other drugs such as sparteine, perhexiline, and other betaadrenoreceptor antagonists. Poor metabolizers of debrisoquine and metoprolol exhibit abnormal pharmacokinetics of metoprolol, which can result in an overdose after administration of a standard dose. There is a clear association between impairment of debrisoquine oxidation and susceptibility to develop liver injury with perhexiline. Does such an association exist for metoprolol? We report the first case of hepatitis induced by metoprolol and the result of drug oxidation phenotyping.
π SIMILAR VOLUMES
## Abstract Traditional herbal formulations, such as Juzenβtaihoβto (TJβ48), are used extensively in medical practice in Asia even though their mechanism of action remains elusive. This study tested a hypothesis that TJβ48 is protective against hepatocarcinogenesis by impeding Kupffer cellβinduced
Background: Thiopurine drugs are widely used in the treatment of inflammatory bowel disease (IBD). The polymorphic enzyme thiopurine S-methyltransferase (TPMT) is of importance for thiopurine metabolism and adverse events occurrence. The role of other thiopurine-metabolizing enzymes is less well kno